This math creates practical challenges during dose escalation
To enroll, one of the following must apply: BMI 27 and an obesity-related comorbid condition BMI 30 with or without comorbid condition Obesity-related comorbid conditions include but are not limited to diabetes, prediabetes, hypertension, dyslipidemia, CAD, osteoarthritis, and obstructive sleep apnea
Ask for a 25-hydroxyvitamin D blood test
Idiopathic Intracranial Hypertension and Obesity IIH is a condition marked by increased cerebrospinal fluid (CSF) pressure without an identifiable underlying cause
I have a gut issue also You'll also get the latest articles directly to your inbox
However, clinicians should also be aware that some individuals receiving tirzepatide may experience gastrointestinal adverse events, which could possibly lead to discontinuation of treatment